Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Trial Data Sharing Remains Low Despite Industry Promises

Despite efforts to encourage the sharing of clinical trial data by drugmakers, the availability of this information to qualified researchers remains low, according to an investigative study appearing in JAMA Oncology this week. In recent years, pharmaceutical industry groups have increasingly promoted policies around the sharing of data from clinical studies, but the extent to which these data are actually made available is unclear. To investigate, a group led by scientists from Flinders University in Australia examined the availability of individual participant data (IPD) from 304 clinical trials that supported the registration of 115 anticancer drugs with the US Food and Drug Administration between 2011 and 2021. Of these trials, the researchers find 168 — 55 percent — were not eligible for IPD sharing, with the most common reason for the lack of data sharing being that the collection of long-term follow-up data was still ongoing. Notably, three of the top 10 cancer drugs based on global sales had the lowest eligibility rates for IPD sharing at less than 10 percent of trials. "Because these trials form the basis of safety and efficacy claims for new medicines, we question whether it is justified that the data are unavailable to independent scrutiny," the study's authors write. "On the basis of our findings, we reiterate calls that transparency policies need updating so that all IPD that inform results presented in a product label or underpin drug registration are immediately eligible for sharing."

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.